Suppr超能文献

一种毒性 RNA 通过细胞和组织中生物正交的四嗪连接反应,利用其自身的荧光抑制剂模板来合成其自身的荧光抑制剂。

A Toxic RNA Templates the Synthesis of Its Own Fluorogenic Inhibitor by Using a Bio-orthogonal Tetrazine Ligation in Cells and Tissues.

机构信息

Department of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, Florida 33458, United States.

出版信息

ACS Chem Biol. 2020 Jul 17;15(7):1820-1825. doi: 10.1021/acschembio.0c00417. Epub 2020 Jun 17.

Abstract

Expanded RNA repeats cause more than 30 incurable diseases. One approach to mitigate their toxicity is by using small molecules that assemble into potent, oligomeric species upon binding to the disease-causing RNA in cells. Herein, we show that the expanded repeat [r(CUG)] that causes myotonic dystrophy type 1 (DM1) catalyzes the synthesis of its own inhibitor using an RNA-templated tetrazine ligation in DM1 patient-derived cells. The compound synthesized on-site improved DM1-associated defects at picomolar concentrations, enhancing potency by 10 000-fold, compared to its parent compounds that cannot undergo oligomerization. A fluorogenic reaction is also described where r(CUG) templates the synthesis of its own imaging probe to enable visualization of the repeat in its native context in live cells and muscle tissue.

摘要

扩展的 RNA 重复序列导致 30 多种无法治愈的疾病。一种减轻其毒性的方法是使用小分子,这些小分子在与细胞中致病的 RNA 结合时会组装成有效、寡聚的物质。在此,我们表明,导致肌萎缩性侧索硬化症 1 型(DM1)的扩展重复 [r(CUG)] 使用在 DM1 患者来源的细胞中基于 RNA 的四嗪连接催化其自身抑制剂的合成。在皮摩尔浓度下,在现场合成的化合物改善了与 DM1 相关的缺陷,与不能进行寡聚化的母体化合物相比,其效力提高了 10000 倍。还描述了一种荧光反应,其中 r(CUG) 模板合成其自身的成像探针,以能够在活细胞和肌肉组织中以其天然构象可视化重复。

相似文献

1
A Toxic RNA Templates the Synthesis of Its Own Fluorogenic Inhibitor by Using a Bio-orthogonal Tetrazine Ligation in Cells and Tissues.
ACS Chem Biol. 2020 Jul 17;15(7):1820-1825. doi: 10.1021/acschembio.0c00417. Epub 2020 Jun 17.
2
A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levels.
Proc Natl Acad Sci U S A. 2019 Oct 15;116(42):20991-21000. doi: 10.1073/pnas.1901893116. Epub 2019 Sep 30.
3
FISH Protocol for Myotonic Dystrophy Type 1 Cells.
Methods Mol Biol. 2020;2056:203-215. doi: 10.1007/978-1-4939-9784-8_13.
4
Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.
Nucleic Acids Res. 2015 Mar 31;43(6):3318-31. doi: 10.1093/nar/gkv163. Epub 2015 Mar 9.
6
Fuchs' Endothelial Corneal Dystrophy and RNA Foci in Patients With Myotonic Dystrophy.
Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4579-4585. doi: 10.1167/iovs.17-22350.
7
Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model.
Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7799-7804. doi: 10.1073/pnas.1901484116. Epub 2019 Mar 29.
9
Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1.
J Am Chem Soc. 2015 Nov 11;137(44):14180-9. doi: 10.1021/jacs.5b09266. Epub 2015 Nov 3.

引用本文的文献

1
Heterobifunctional small molecules to modulate RNA function.
Trends Pharmacol Sci. 2024 May;45(5):449-463. doi: 10.1016/j.tips.2024.03.006. Epub 2024 Apr 18.
2
Targeting RNA structures with small molecules.
Nat Rev Drug Discov. 2022 Oct;21(10):736-762. doi: 10.1038/s41573-022-00521-4. Epub 2022 Aug 8.

本文引用的文献

1
Intrinsically cell-penetrating multivalent and multitargeting ligands for myotonic dystrophy type 1.
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):8709-8714. doi: 10.1073/pnas.1820827116. Epub 2019 Apr 11.
2
Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model.
Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7799-7804. doi: 10.1073/pnas.1901484116. Epub 2019 Mar 29.
4
Inverse electron demand Diels-Alder reactions in chemical biology.
Chem Soc Rev. 2017 Aug 14;46(16):4895-4950. doi: 10.1039/c7cs00184c.
5
Precise small-molecule recognition of a toxic CUG RNA repeat expansion.
Nat Chem Biol. 2017 Feb;13(2):188-193. doi: 10.1038/nchembio.2251. Epub 2016 Dec 12.
6
Programmable RNA Tracking in Live Cells with CRISPR/Cas9.
Cell. 2016 Apr 7;165(2):488-96. doi: 10.1016/j.cell.2016.02.054. Epub 2016 Mar 17.
7
Oral administration of erythromycin decreases RNA toxicity in myotonic dystrophy.
Ann Clin Transl Neurol. 2015 Dec 10;3(1):42-54. doi: 10.1002/acn3.271. eCollection 2016 Jan.
8
Actinomycin D Specifically Reduces Expanded CUG Repeat RNA in Myotonic Dystrophy Models.
Cell Rep. 2015 Dec 22;13(11):2386-2394. doi: 10.1016/j.celrep.2015.11.028. Epub 2015 Dec 10.
9
A toxic RNA catalyzes the in cellulo synthesis of its own inhibitor.
Angew Chem Int Ed Engl. 2014 Oct 6;53(41):10956-9. doi: 10.1002/anie.201406465. Epub 2014 Aug 27.
10
Splicing biomarkers of disease severity in myotonic dystrophy.
Ann Neurol. 2013 Dec;74(6):862-72. doi: 10.1002/ana.23992.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验